PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-261

  1. 643 Posts.
    lightbulb Created with Sketch. 121
    Me too,@Werble. I accept that others have legitimate concerns, though. Many here seem to know a lot more about science and/or stock markets than I do, but I look at what other 'speculative' pre-revenue stocks on my watchlist have done and they have been erratic and unpredictable - even with tangible, proven assets such as in mining. I'm down around 50% on my PAR holding, have been down for years, but I'm still excited and optimistic.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.